1. Home
  2. FOLD vs KLIC Comparison

FOLD vs KLIC Comparison

Compare FOLD & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • KLIC
  • Stock Information
  • Founded
  • FOLD 2002
  • KLIC 1951
  • Country
  • FOLD United States
  • KLIC United States
  • Employees
  • FOLD N/A
  • KLIC N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • KLIC Semiconductors
  • Sector
  • FOLD Health Care
  • KLIC Technology
  • Exchange
  • FOLD Nasdaq
  • KLIC Nasdaq
  • Market Cap
  • FOLD 2.9B
  • KLIC 2.7B
  • IPO Year
  • FOLD 2007
  • KLIC N/A
  • Fundamental
  • Price
  • FOLD $9.80
  • KLIC $46.95
  • Analyst Decision
  • FOLD Strong Buy
  • KLIC Strong Buy
  • Analyst Count
  • FOLD 8
  • KLIC 5
  • Target Price
  • FOLD $16.71
  • KLIC $52.40
  • AVG Volume (30 Days)
  • FOLD 2.8M
  • KLIC 561.6K
  • Earning Date
  • FOLD 11-06-2024
  • KLIC 01-29-2025
  • Dividend Yield
  • FOLD N/A
  • KLIC 1.70%
  • EPS Growth
  • FOLD N/A
  • KLIC N/A
  • EPS
  • FOLD N/A
  • KLIC N/A
  • Revenue
  • FOLD $493,671,000.00
  • KLIC $706,232,000.00
  • Revenue This Year
  • FOLD $34.30
  • KLIC $10.37
  • Revenue Next Year
  • FOLD $21.78
  • KLIC $17.29
  • P/E Ratio
  • FOLD N/A
  • KLIC N/A
  • Revenue Growth
  • FOLD 32.58
  • KLIC N/A
  • 52 Week Low
  • FOLD $9.02
  • KLIC $38.20
  • 52 Week High
  • FOLD $14.57
  • KLIC $56.71
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 45.87
  • KLIC 43.91
  • Support Level
  • FOLD $9.41
  • KLIC $48.43
  • Resistance Level
  • FOLD $9.99
  • KLIC $52.08
  • Average True Range (ATR)
  • FOLD 0.35
  • KLIC 1.69
  • MACD
  • FOLD 0.03
  • KLIC -0.37
  • Stochastic Oscillator
  • FOLD 48.15
  • KLIC 8.72

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About KLIC Kulicke and Soffa Industries Inc.

Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.

Share on Social Networks: